Our mission is to unlock the environmental, social and economic utility of cannabis by developing, producing and delivering premium quality and high performing cannabis brands and products internationally.
C21’s Nevada Dispensaries Achieve Record Retail Revenue for Q2 VANCOUVER, August 4, 2020 – C21 Investments Inc. (“C21” or the “Company”) (CSE: CXXI and OTCQB: CXXIF) today announced record revenue at its Nevada dispensaries for its second quarter (“Q2” ending...
C21 Investments Announces Year End Results VANCOUVER, July 13, 2020 – C21 Investments Inc. (“C21” or “The Company”) (CSE: CXXI and OTCQB: CXXIF) today announces audited results for its fiscal year end of January 31, 2020. Highlights: (all currency in...
C21 Investments Inc. (“C21 Investments” or the "Company") (CSE: CXII and OTC: CXXIF) advises that it has reached agreement to restructure payments under a US$30 million promissory note issued on January 15, 2019 (“Note”) to Mr. Sonny Newman in connection with...
C21 Investments Inc. (the “Company”) (CSE: CXXI and OTC: CXXIF) today announced unaudited revenue of US$7.7 million for the 1st quarter ended April 30, 2019. This amount reflects revenue from the Company’s operations in Nevada and Oregon. Unaudited gross margin...
C21 Investments, Inc. (CSE: CXXI) today announced the launch of a new product: the Phantom Vape Pen. The highly anticipated vape pen solves a number of industry challenges by providing uniform viscosity, shelf stability, oil clarity as well as consistency...
C21 Investments, Inc. (CSE: CXXI) today announced that it has received approval from the Oregon Liquor Control Commission for the transfer of all the operating licenses of Swell Companies in Oregon. The formal closing of the acquisition of the Swell...